BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35926290)

  • 1. The utility of PAX8 in comparison with PAX5 immunohistochemical staining in the diagnosis of Hodgkin lymphoma.
    Ameli F; Zahavi Z; Kosari F; Soleimani V
    Ann Diagn Pathol; 2022 Oct; 60():151974. PubMed ID: 35926290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.
    Morgan EA; Pozdnyakova O; Nascimento AF; Hirsch MS
    Histopathology; 2013 Feb; 62(3):406-13. PubMed ID: 23163626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma.
    Kosari F; Bakhshi T; Ameli F; Mokhtari M
    BMC Cancer; 2022 Dec; 22(1):1359. PubMed ID: 36577979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas.
    Moretti L; Medeiros LJ; Kunkalla K; Williams MD; Singh RR; Vega F
    Mod Pathol; 2012 Feb; 25(2):231-6. PubMed ID: 22037256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Utility of PAX5 in Hodgkin and Non-Hodgkin Lymphoma: A Study from Northern India.
    Johri N; Patne SC; Tewari M; Kumar M
    J Clin Diagn Res; 2016 Aug; 10(8):XC04-XC07. PubMed ID: 27656544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody.
    Toriyama A; Mori T; Sekine S; Yoshida A; Hino O; Tsuta K
    Histopathology; 2014 Oct; 65(4):465-72. PubMed ID: 24592933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and differential diagnosis of nodular lymphocyte-predominant Hodgkin's lymphoma.
    Liu Y; Zhu X; Zhuang H; Lin H; Wu Q; Jiang G; Gu Y; Luo D; Luo X
    Zhonghua Bing Li Xue Za Zhi; 2002 Jun; 31(3):227-30. PubMed ID: 12475440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma.
    Steimle-Grauer SA; Tinguely M; Seada L; Fellbaum C; Hansmann ML
    Virchows Arch; 2003 Mar; 442(3):284-93. PubMed ID: 12647220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays.
    McCune RC; Syrbu SI; Vasef MA
    Mod Pathol; 2006 Jul; 19(7):1010-8. PubMed ID: 16648862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
    Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
    Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine-needle aspiration cytology samples.
    Cozzolino I; Vitagliano G; Caputo A; Montella M; Franco R; Ciancia G; Selleri C; Zeppa P
    Diagn Cytopathol; 2020 Mar; 48(3):211-216. PubMed ID: 31825183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma].
    Zhou X; Zhao T; Qi Z; Liu G; Zhu M
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1532-5. PubMed ID: 12609061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
    Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
    Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.
    Feldman AL; Law ME; Inwards DJ; Dogan A; McClure RF; Macon WR
    Mod Pathol; 2010 Apr; 23(4):593-602. PubMed ID: 20118907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
    Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
    Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma.
    Li W; Blessin NC; Simon R; Kluth M; Fischer K; Hube-Magg C; Makrypidi-Fraune G; Wellge B; Mandelkow T; Debatin NF; Pott L; Höflmayer D; Lennartz M; Sauter G; Izbicki JR; Minner S; Büscheck F; Uhlig R; Dum D; Krech T; Luebke AM; Wittmer C; Jacobsen F; Burandt E; Steurer S; Wilczak W; Hinsch A
    BMC Cancer; 2018 Dec; 18(1):1209. PubMed ID: 30514251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.
    van Grotel M; Lam KH; de Man R; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
    Leuk Lymphoma; 2006 Aug; 47(8):1504-10. PubMed ID: 16966260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.
    Bhargava P; Pantanowitz L; Pinkus GS; Pinkus JL; Paessler ME; Roullet M; Gautam S; Bagg A; Kadin ME
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):16-23. PubMed ID: 19550297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.